Duncker Streett & Co’s VanEck Pharmaceutical ETF PPH Stock Holding History

Duncker Streett & Co’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.53K	Buy	+78	New	+$8.07K	﹤0.01%	425

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Duncker Streett & Co's PPH Position: Q2 2026 in Review

Duncker Streett & Co opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 78 shares worth $8.53K. The stake represents ﹤0.01% of the portfolio and ranks #425 among its holdings.

148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Duncker Streett & Co held 78 shares of VanEck Pharmaceutical ETF worth $8.53K as of Q2 2026.
VanEck Pharmaceutical ETF was a new Duncker Streett & Co position in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #425 holding.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.